| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |